IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

OUP Management Co., LLC

Q1 2023 Holdings

Filed 2023-04-24 | 14 holdings | $50.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aerovate Therapeutics Inc.Common Stock008064107$12.2M603,76224.3%
Centessa Pharmaceuticals plc(CNTA)Sponsored ADS152309100$11.3M2,937,61522.6%
Dice Therapeutics Inc.Common Stock23345J104$7.7M268,34615.3%
PMV Pharmaceuticals, Inc.(PMVP)Common Stock69353Y103$4.7M989,2329.4%
Cyteir Therapeutics, Inc.Common Stock23284P103$4.5M2,459,5728.9%
ionQ, Inc.(IONQ)Common Stock46222L108$2.4M389,6684.8%
Vor Biopharma Inc.Common Stock929033108$2.0M374,7144.0%
Prime Medicine, Inc.(PRME)Common Stock74168J101$1.5M121,2553.0%
Selecta Biosciences, Inc.(SELBUSD)Common Stock816212104$1.2M862,5432.4%
Graphite Bio(GRPH)Common Stock38870X104$995.5K406,3082.0%
Precision BioSciences, Inc.Common Stock74019P108$847.0K1,123,9131.7%
eFFECTOR Therapeutics, Inc.Common Stock28202V108$361.8K1,025,6970.7%
Spero Therapeutics, Inc.(SPRO)Common Stock84833T103$361.2K249,0700.7%
Homology Medicines, Inc.Common Stock438083107$65.9K64,0000.1%